1:2:1 Podcast : Cardiovascular Health
Euan Ashley on harnessing the power of genomics
A few years ago, Stanford cardiologist Euan Ashley, MD, described the promise of genomics for diagnosing and treating diseases as the "wild west" - a lot of researchers examining ways of using the technique, but too early to have meaningful results in the clinic. Since then, much has changed in the field.
A change of heart: A conversation with Dick Cheney
Dick Cheney has lived with chronic heart disease for virtually all of his adult life. At 37, as a young man running for the U.S. Congress in Wyoming, he had his first heart attack. His last – a fifth – occurred in 2010 and by then having taken advantage of everything medicine and technology had to offer, the former vice president knew he was at the end of the road.
Euan Ashley on genome sequencing
Cardiologist Euan Ashley, MD, and bioengineer Stephen Quake, PhD, are two members of an extensive team of clinicians, geneticists, bioethicists and bioinformaticians at Stanford's School of Medicine who worked together to devise the first-ever clinical recommendation based on a person's entire genomic sequence.
Mark Hlatky on statins
A major study recently showed that cholesterol-lowering drugs called statins can dramatically decrease the risk of heart attacks and strokes for millions more people. In an accompanying editorial in the New England Journal of Medicine, however, Mark Hlatky, MD, professor of health research and policy and of cardiovascular medicine, urged caution in the prescription of these drugs to seemingly healthy patients. He discusses the implications of the study's findings.